CD82 Antikörper (Middle Region)
-
- Target Alle CD82 Antikörper anzeigen
- CD82
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD82 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- ELIRDYNSSR EDSLQDAWDY VQAQVKCCGW VSFYNWTDNA ELMNRPEVTY
- Homologie
- Human: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against CD82. It was validated on Western Blot.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of CD82
- Top Product
- Discover our top product CD82 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 242 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- Target
- CD82
- Andere Bezeichnung
- CD82 (CD82 Produkte)
- Synonyme
- AA682076 antikoerper, AL023070 antikoerper, C33 antikoerper, IA4 antikoerper, Kai1 antikoerper, Tspan27 antikoerper, 4F9 antikoerper, GR15 antikoerper, KAI1 antikoerper, R2 antikoerper, SAR2 antikoerper, ST6 antikoerper, TSPAN27 antikoerper, CD82 antigen antikoerper, CD82 molecule antikoerper, Cd82 molecule antikoerper, Cd82 antikoerper, CD82 antikoerper
- Hintergrund
-
This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
Alias Symbols: 4F9, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27
Protein Interaction Partner: GGT1, CD81, CD53, UBC, LGALS3BP, AMFR, VANGL1, IGSF8, ITGA3, NUP88, PTGFRN, ITGB2, ITGA4, ERBB3, CD4, ERBB2, CD63, ITGA6, HLA-DRA, HLA-DMB, HLA-DMA, ITGB1, EGFR, HBEGF, CANX, LRP1, CD19, ITGAL, HLA-DOB, CD46, CD151, CD9, RUVBL1, POLR2A, KAT5, CTNNB1, RUVB
Protein Size: 242 - Molekulargewicht
- 27 kDa
- Gen-ID
- 3732
- NCBI Accession
- NM_001024844, NP_001020015
- UniProt
- P27701
- Pathways
- p53 Signalweg
-